drugset / Trial / NCT00496782
Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay
NaSingle-groupOpen-labelScreening
Summary
The purpose of this pilot study is to determine whether there is a correlation between viral load reduction (at Day 4, 7 or 14) following a short course (14 days) of Maraviroc added to a failing regimen, and the R5 result of the TrofileTM assay at screening.
Timeline
- Start
- 2007-07
- Primary completion
- 2008-10
- Completion
- 2008-10
Outcome
Outcome not reported
Stopped: “See Detailed Description”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Maraviroc | Other / unclassified | 150 mg | — |
| Subject | Maraviroc | Other / unclassified | 300 mg | — |
| Subject | Maraviroc | Other / unclassified | 600 mg | — |